stella
beta
A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies — Stella
Recruiting
Back to Advanced Hematologic Malignancies trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(3 sites)
China
The Henan Cancer Hospital, Zhengzhou, Henan
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov